Alliance Global Partners Initiates Coverage On Fortress Biotech With Buy Rating, Announces Price Target of $5
Alliance Global Partners Initiates Coverage On Fortress Biotech With Buy Rating, Announces Price Target of $5
Alliance Global Partners以買入評級啓動對豐澤生物技術的報道，宣佈目標股價爲5美元
Alliance Global Partners initiates coverage on Fortress Biotech (NASDAQ:FBIO) with a Buy rating and announces Price Target of $5.
Alliance Global Partners開始對豐澤生物科技（納斯達克股票代碼：FBIO）進行報道，評級爲買入，並宣佈目標股價爲5美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。